Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Jul;73(861):403–408. doi: 10.1136/pgmj.73.861.403

Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosis.

P Vanhems 1, R Beaulieu 1
PMCID: PMC2431388  PMID: 9338024

Abstract

Primary infection by type 1 human immunodeficiency virus (HIV) is symptomatic in about 70% of cases. The acute illness is a mononucleosis-like syndrome with characteristics such as mucosal ulcerations. The duration and severity of the symptoms appear to be related to the prognosis. After reviewing the most frequent signs and symptoms of primary HIV infection, we report different prognostic studies which examined the association between the acute illness and the progression of HIV disease.

Full text

PDF
403

Images in this article

404Figure 1
on p.404
404Figure 2
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumberger C., Kinloch-de-Loës S., Yerly S., Hirschel B., Perrin L. High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS. 1993 Nov;7 (Suppl 2):S59–S64. doi: 10.1097/00002030-199311002-00013. [DOI] [PubMed] [Google Scholar]
  2. Biggar R. J. AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS. 1990 Nov;4(11):1059–1066. doi: 10.1097/00002030-199011000-00002. [DOI] [PubMed] [Google Scholar]
  3. Calabrese L. H., Proffitt M. R., Levin K. H., Yen-Lieberman B., Starkey C. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med. 1987 Dec;107(6):849–851. doi: 10.7326/0003-4819-107-6-849. [DOI] [PubMed] [Google Scholar]
  4. Carré N., Deveau C., Belanger F., Boufassa F., Persoz A., Jadand C., Rouzioux C., Delfraissy J. F., Bucquet D. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS. 1994 Jun;8(6):797–802. doi: 10.1097/00002030-199406000-00012. [DOI] [PubMed] [Google Scholar]
  5. Cooper D. A., Gold J., Maclean P., Donovan B., Finlayson R., Barnes T. G., Michelmore H. M., Brooke P., Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. doi: 10.1016/s0140-6736(85)91205-x. [DOI] [PubMed] [Google Scholar]
  6. Cooper D. A. HIV therapy advances. Early antiretroviral therapy. AIDS. 1994 Sep;8 (Suppl 3):S9–14. [PubMed] [Google Scholar]
  7. Erice A., Mayers D. L., Strike D. G., Sannerud K. J., McCutchan F. E., Henry K., Balfour H. H., Jr Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med. 1993 Apr 22;328(16):1163–1165. doi: 10.1056/NEJM199304223281605. [DOI] [PubMed] [Google Scholar]
  8. Fabio G., Marchini M., Scorza Smeraldi R., Zarantonello M., Tarantini G., Gringeri A., Antonioli R. Possible association of HLA-DR2 phenotype and detectable human immunodeficiency virus (HIV) p24 antigen in HIV-positive patients. J Infect Dis. 1993 Feb;167(2):499–500. doi: 10.1093/infdis/167.2.499. [DOI] [PubMed] [Google Scholar]
  9. Farzadegan H., Chmiel J. S., Odaka N., Ward L., Poggensee L., Saah A., Phair J. P. Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time. J Infect Dis. 1992 Dec;166(6):1217–1222. doi: 10.1093/infdis/166.6.1217. [DOI] [PubMed] [Google Scholar]
  10. Fauci A. S. Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr. 1993 Jun;6(6):655–662. [PubMed] [Google Scholar]
  11. Gaines H., von Sydow M., Pehrson P. O., Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ. 1988 Nov 26;297(6660):1363–1368. doi: 10.1136/bmj.297.6660.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Itescu S., Brancato L. J., Buxbaum J., Gregersen P. K., Rizk C. C., Croxson T. S., Solomon G. E., Winchester R. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med. 1990 Jan 1;112(1):3–10. doi: 10.7326/0003-4819-112-1-3. [DOI] [PubMed] [Google Scholar]
  13. Kaslow R. A., Duquesnoy R., VanRaden M., Kingsley L., Marrari M., Friedman H., Su S., Saah A. J., Detels R., Phair J. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet. 1990 Apr 21;335(8695):927–930. doi: 10.1016/0140-6736(90)90995-h. [DOI] [PubMed] [Google Scholar]
  14. Keet I. P., Krijnen P., Koot M., Lange J. M., Miedema F., Goudsmit J., Coutinho R. A. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS. 1993 Jan;7(1):51–57. doi: 10.1097/00002030-199301000-00008. [DOI] [PubMed] [Google Scholar]
  15. Kinloch-De Loës S., Hirschel B. J., Hoen B., Cooper D. A., Tindall B., Carr A., Saurat J. H., Clumeck N., Lazzarin A., Mathiesen L. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med. 1995 Aug 17;333(7):408–413. doi: 10.1056/NEJM199508173330702. [DOI] [PubMed] [Google Scholar]
  16. Kinloch-de Loës S., de Saussure P., Saurat J. H., Stalder H., Hirschel B., Perrin L. H. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993 Jul;17(1):59–65. doi: 10.1093/clinids/17.1.59. [DOI] [PubMed] [Google Scholar]
  17. Ku L., Sonenstein F. L., Pleck J. H. Young men's risk behaviors for HIV infection and sexually transmitted diseases, 1988 through 1991. Am J Public Health. 1993 Nov;83(11):1609–1615. doi: 10.2105/ajph.83.11.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lifson A. R., Buchbinder S. P., Sheppard H. W., Mawle A. C., Wilber J. C., Stanley M., Hart C. E., Hessol N. A., Holmberg S. D. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics. J Infect Dis. 1991 May;163(5):959–965. doi: 10.1093/infdis/163.5.959. [DOI] [PubMed] [Google Scholar]
  19. Lifson A. R., Hilton J. F., Westenhouse J. L., Canchola A. J., Samuel M. C., Katz M. H., Buchbinder S. P., Hessol N. A., Osmond D. H., Shiboski S. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS. 1994 Jan;8(1):73–79. doi: 10.1097/00002030-199401000-00011. [DOI] [PubMed] [Google Scholar]
  20. Lindbäck S., Broström C., Karlsson A., Gaines H. Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS? BMJ. 1994 Dec 10;309(6968):1535–1537. doi: 10.1136/bmj.309.6968.1535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Niu M. T., Stein D. S., Schnittman S. M. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections. J Infect Dis. 1993 Dec;168(6):1490–1501. doi: 10.1093/infdis/168.6.1490. [DOI] [PubMed] [Google Scholar]
  22. Niu M. T., Stein D. S., Schnittman S. M. Treatment trials for primary human immunodeficiency virus type 1 infection. J Infect Dis. 1993 Dec;168(6):1601–1602. doi: 10.1093/infdis/168.6.1601. [DOI] [PubMed] [Google Scholar]
  23. Pantaleo G., Fauci A. S. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol. 1995;13:487–512. doi: 10.1146/annurev.iy.13.040195.002415. [DOI] [PubMed] [Google Scholar]
  24. Pedersen C., Lindhardt B. O., Jensen B. L., Lauritzen E., Gerstoft J., Dickmeiss E., Gaub J., Scheibel E., Karlsmark T. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ. 1989 Jul 15;299(6692):154–157. doi: 10.1136/bmj.299.6692.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 Mar 19;259(5102):1749–1754. doi: 10.1126/science.8096089. [DOI] [PubMed] [Google Scholar]
  26. Richman D. D. Resistance, drug failure, and disease progression. AIDS Res Hum Retroviruses. 1994 Aug;10(8):901–905. doi: 10.1089/aid.1994.10.901. [DOI] [PubMed] [Google Scholar]
  27. Roos M. T., Lange J. M., de Goede R. E., Coutinho R. A., Schellekens P. T., Miedema F., Tersmette M. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis. 1992 Mar;165(3):427–432. doi: 10.1093/infdis/165.3.427. [DOI] [PubMed] [Google Scholar]
  28. Schechter M. T., Craib K. J., Le T. N., Montaner J. S., Douglas B., Sestak P., Willoughby B., O'Shaughnessy M. V. Susceptibility to AIDS progression appears early in HIV infection. AIDS. 1990 Mar;4(3):185–190. doi: 10.1097/00002030-199003000-00002. [DOI] [PubMed] [Google Scholar]
  29. Stein D. S., Korvick J. A., Vermund S. H. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992 Feb;165(2):352–363. doi: 10.1093/infdis/165.2.352. [DOI] [PubMed] [Google Scholar]
  30. Stein D. S., Korvick J. A., Vermund S. H. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992 Feb;165(2):352–363. doi: 10.1093/infdis/165.2.352. [DOI] [PubMed] [Google Scholar]
  31. Tindall B., Barker S., Donovan B., Barnes T., Roberts J., Kronenberg C., Gold J., Penny R., Cooper D. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988 Apr;148(4):945–949. [PubMed] [Google Scholar]
  32. Ward J. W., Bush T. J., Perkins H. A., Lieb L. E., Allen J. R., Goldfinger D., Samson S. M., Pepkowitz S. H., Fernando L. P., Holland P. V. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med. 1989 Oct 5;321(14):947–952. doi: 10.1056/NEJM198910053211406. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES